Tectonic Therapeutic (TECX) said Monday it expects to raise about $185 million in gross proceeds through a private investment in public equity financing.
The company will issue 3,689,465 common shares at $50 apiece to fund investors and $54.14 per share to individual investors who serve as either an officer or director of Tectonic.
The company said the financing included participation from new and existing investors, including Adage Capital Partners, Ally Bridge Group, Deep Track Capital, EcoR1 Capital, and funds managed by Farallon Capital Management.
Tectonic expects the financing to close Wednesday and expects to use net proceeds to fund the clinical development of TX45 and TX2100, among other things.
Shares were 0.5% higher in recent trading.
Price: 54.44, Change: +0.30, Percent Change: +0.54
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。